AC
AI Cancer Cure
Evidence Atlas, updating nightly
Trials
Research
Support
Alternatives
Cancers
Biomarkers
Updates
Roadmap
Explore
← Back to trials
Trial not found
Could not find
NCT07067268
in the database yet.
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy | AI Cancer Cure